Lupin Limited (BSE:500257) is seeking to acquire US brands to grow its portfolio. It is looking to acquire companies that can give it technological advantage and more market access and also look at pharma companies in other EMs (emerging markets) such as Brazil and Mexico.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,587 INR | +1.85% |
|
+0.90% | +19.93% |
06-17 | Lupin Appoints CEO for Subsidiary Lupin Manufacturing Solutions | MT |
06-14 | Lupin Gets Zero Observations from US FDA After Nagpur, India Unit Inspection | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.93% | 8.51B | |
+55.19% | 815B | |
+47.26% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.40% | 247B | |
+3.64% | 229B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- LUPIN Stock
- News Lupin Limited
- Lupin Mulls To Acquire US Brands